SPECT Studies with the I-123-labeled Dopamine Transporter Ligands FP-CIT (DaTSCAN(TM)) DGN Recommendation for Action (S1 Guideline)

Tatsch K, Buchert R, Bartenstein P, Barthel H, Boecker H, Brust P, Drzezga A, La Fougere C, Gruender G, Gruenwald F, Krause BJ, Kuwert T, Langen KJ, Rominger A, Sabri O, Schreckenberger M, Meyer PT (2019)


Publication Type: Journal article, Editorial

Publication year: 2019

Journal

Book Volume: 58

Pages Range: 5-14

Journal Issue: 1

DOI: 10.1055/a-0807-8137

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Tatsch, K., Buchert, R., Bartenstein, P., Barthel, H., Boecker, H., Brust, P.,... Meyer, P.T. (2019). SPECT Studies with the I-123-labeled Dopamine Transporter Ligands FP-CIT (DaTSCAN(TM)) DGN Recommendation for Action (S1 Guideline). Nuklearmedizin-Nuclear Medicine, 58(1), 5-14. https://dx.doi.org/10.1055/a-0807-8137

MLA:

Tatsch, Klaus, et al. "SPECT Studies with the I-123-labeled Dopamine Transporter Ligands FP-CIT (DaTSCAN(TM)) DGN Recommendation for Action (S1 Guideline)." Nuklearmedizin-Nuclear Medicine 58.1 (2019): 5-14.

BibTeX: Download